Together, these findings suggest that rosacea and AD share convergent transcriptomic signatures, particularly NF-κB/IL-17/TNF-driven inflammation and vascular remodelling, while pointing to melatonin as a potential modulator. This evidence concerns the gene NFKB1 and Alzheimer disease.